Gumintad, Lea Mae P.
HRN: 24-99-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/15/2024
05/15/2024
Q8
65 Mg
IV
T/c Ileus
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes